Differences in the Direction of Change of Cerebral Function Parameters Are Evident over Three Years in HIV-Infected Individuals Electively Commencing Initial cART
暂无分享,去创建一个
A. Winston | S. Taylor-Robinson | D. Cooper | C. Duncombe | S. Kerr | S. Emery | Patrick C. K. Li | J. M. Gill | R. Puls | R. Ramautarsing
[1] Caroline Rae,et al. HIV, Vascular and Aging Injuries in the Brain of Clinically Stable HIV-Infected Adults: A 1H MRS Study , 2013, PloS one.
[2] Jintanat Ananworanich,et al. Change in Brain Magnetic Resonance Spectroscopy after Treatment during Acute HIV Infection , 2012, PloS one.
[3] A. Winston,et al. Dynamics of cognitive change in HIV‐infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled study , 2012, HIV medicine.
[4] D. Clifford,et al. Minocycline treatment for HIV-associated cognitive impairment , 2011, Neurology.
[5] Susan Morgello,et al. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy , 2011, AIDS.
[6] N. Ciccarelli,et al. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients , 2011, Neurology.
[7] B. Gazzard,et al. Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] Dan J Stein,et al. Does highly active antiretroviral therapy improve neurocognitive function? A systematic review , 2010, Journal of NeuroVirology.
[9] A. Winston,et al. Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] A. Winston,et al. Does acute hepatitis C infection affect the central nervous system in HIV‐1 infected individuals? , 2009, Journal of viral hepatitis.
[11] A. Winston,et al. Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapy. , 2009, AIDS research and human retroviruses.
[12] F. Vaida,et al. Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy , 2009, Neurology.
[13] Thomas Ernst,et al. Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV , 2008, Journal of the International Neuropsychological Society.
[14] C. Hall,et al. Effects of antiretroviral therapy on cognitive impairment , 2008, Current HIV/AIDS reports.
[15] Yuji Nakamoto,et al. Reproducibility of magnetic resonance spectroscopy in correlation with signal-to-noise ratio , 2007, Psychiatry Research: Neuroimaging.
[16] P. Maruff,et al. The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. , 2006, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.
[17] Michael J. Taylor,et al. Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors , 2005, Journal of NeuroVirology.
[18] Johannes Bernarding,et al. Quantitation of simulated short echo time 1H human brain spectra by LCModel and AMARES , 2004, Magnetic resonance in medicine.
[19] Linda Chang,et al. Antiretroviral Treatment Alters Relationship between Mcp-1 and Neurometabolites in HIV Patients , 2003, Antiviral therapy.
[20] Paul Maruff,et al. The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals. , 2003, Journal of the International Neuropsychological Society : JINS.
[21] J. Walecki,et al. Antiretroviral therapy and its influence on the stage of brain damage in patients with HIV - 1H MRS evaluation. , 1999, Medical science monitor : international medical journal of experimental and clinical research.
[22] L. Chang,et al. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia , 1999, Neurology.
[23] I. Wilkinson,et al. Proton MRS and quantitative MRI assessment of the short term neurological response to antiretroviral therapy in AIDS , 1997, Journal of neurology, neurosurgery, and psychiatry.
[24] H. Gendelman,et al. Prospective utility of cerebral proton magnetic resonance spectroscopy in monitoring HIV infection and its associated neurological impairment. , 1994, AIDS research and human retroviruses.
[25] K. Robertson,et al. Antiretroviral neurotoxicity , 2012, Journal of NeuroVirology.